Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Equities
603707
CNE100002WP3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.88 CNY | -1.49% |
|
-2.54% | -20.80% |
28/06 | NKFPharma's Unit Buys Yusimry's Rights for $40 Million | MT |
26/06 | Nanjing King-Friend Biochemical Pharmaceutical Gets Drug Registration Approval for Anti-Nausea Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.80% | 267.18Cr | |
+55.32% | 82TCr | |
-6.75% | 35TCr | |
+13.56% | 33TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+2.04% | 23TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr | |
-2.81% | 16TCr |
- Stock Market
- Equities
- 603707 Stock
- News Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
- Nanjing King-Friend Biochemical Pharmaceutical Gets Drug Registration Approval for Anti-Nausea Drug